Cannara Biotech Inc (LOVE) Stock Price & News

LOVE:TSE

Cannara Biotech Inc

CA$1.99

+1.53%

(+0.030) 1D

Sep 11, 4:00:00 PM GMT-4 · CAD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Jul 15, 2026

Fiscal period

Q3 2026

EPS / Est. (CAD)

CA$0.04 / CA$0.04

+11.14%beat

Revenue / Est. (CAD)

31.83M / 31.23M

+1.90%beat

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in CAD

Loading Previous Earnings...

All values in CAD	Aug 2025	Nov 2025	Feb 2026	May 2026
Revenue	28.52M	30.11M	27.18M	31.83M
Cost of goods sold	16.13M	18.90M	15.53M	16.80M
Cost of revenue	16.13M	18.90M	15.53M	16.80M
Research and development expenses	191.15K	287.45K	400.70K	344.72K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.02M	6.23M	6.50M	6.30M
Operating expense	7.30M	8.51M	8.25M	7.67M
Total operating expenses	23.43M	27.41M	23.78M	24.47M
Operating income	5.09M	2.70M	3.40M	7.36M
Other non operating income	-379.12K	-73.54K	-126.60K	-113.09K
EBT including unusual items	4.54M	2.04M	2.82M	6.87M
EBT excluding unusual items	4.00M	2.04M	2.94M	6.87M
Income tax expense	1.23M	1.00M	1.16M	2.03M
Effective tax rate	27.03%	49.07%	41.04%	29.54%
Other operating expenses	-	-	-	-
Net income	3.31M	1.04M	1.66M	4.84M
Net profit margin	11.62%	3.45%	6.12%	15.21%
Earnings per share	-	-	0.02	0.04
Interest and investment income	89.58K	82.70K	84.27K	141.63K
Interest expense	-805.27K	-608.11K	-465.53K	-492.85K
Net interest expenses	-715.69K	-525.41K	-381.26K	-351.22K
Depreciation and amortization charges	-	266.74K	252.99K	238.30K
EBITDA	7.26M	4.22M	4.64M	8.93M
Gain or loss from assets sale	-422.17K	-	122.01K	-

Finance